Turtle Creek Wealth Advisors LLC Buys 3,163 Shares of Stryker Corporation $SYK

Key Points

• Turtle Creek Wealth Advisors LLC increased its stake in Stryker by 15.6%, buying 3,163 shares to hold 23,376 shares valued at about $8.22 million at the end of the quarter, while institutional investors own roughly 77.09% of the stock.
• Director Ronda E. Stryker sold 250,000 shares on Feb. 4 at an average price of $362.92 for about $90.73 million, reducing her ownership by 9.23%; insiders now hold 4.60% of Stryker.
• Stryker beat quarterly earnings (EPS $4.47 vs. $4.40) with revenue of $7.17B (+11.4% y/y), declared a $0.88 quarterly dividend (annualized $3.52, ~1.1% yield), and carries a "Moderate Buy" consensus with an average target of $421.11.

Turtle Creek Wealth Advisors LLC increased its stake in Stryker Corporation (NYSE:SYK - Free Report) by 15.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,376 shares of the medical technology company's stock after buying an additional 3,163 shares during the period. Turtle Creek Wealth Advisors LLC's holdings in Stryker were worth $8,216,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. B. Metzler seel. Sohn & Co. AG increased its stake in shares of Stryker by 1.3% during the fourth quarter. B. Metzler seel. Sohn & Co. AG now owns 77,783 shares of the medical technology company's stock valued at $27,357,000 after purchasing an additional 981 shares in the last quarter. Mystic Asset Management Inc. increased its stake in shares of Stryker by 0.3% during the fourth quarter. Mystic Asset Management Inc. now owns 15,941 shares of the medical technology company's stock valued at $5,603,000 after purchasing an additional 47 shares in the last quarter. Cranbrook Wealth Management LLC increased its stake in shares of Stryker by 17.9% during the fourth quarter. Cranbrook Wealth Management LLC now owns 5,604 shares of the medical technology company's stock valued at $1,970,000 after purchasing an additional 849 shares in the last quarter. West Michigan Advisors LLC increased its stake in shares of Stryker by 0.4% during the fourth quarter. West Michigan Advisors LLC now owns 7,468 shares of the medical technology company's stock valued at $2,631,000 after purchasing an additional 30 shares in the last quarter. Finally, Harbour Trust & Investment Management Co increased its stake in shares of Stryker by 7.7% during the fourth quarter. Harbour Trust & Investment Management Co now owns 44,382 shares of the medical technology company's stock valued at $15,599,000 after purchasing an additional 3,160 shares in the last quarter. 77.09% of the stock is owned by institutional investors.

Insider Activity at Stryker

In other news, Director Ronda E. Stryker sold 250,000 shares of the stock in a transaction that occurred on Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the sale, the director owned 2,457,331 shares in the company, valued at $891,814,566.52. This represents a 9.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 4.60% of the stock is currently owned by insiders.

Stryker Trading Up 0.1%

NYSE:SYK opened at $329.65 on Friday. The company's 50 day moving average price is $350.54 and its 200-day moving average price is $358.60. Stryker Corporation has a 52 week low of $319.32 and a 52 week high of $404.87. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66. The stock has a market cap of $126.25 billion, a price-to-earnings ratio of 39.24, a PEG ratio of 1.93 and a beta of 0.92.

Stryker (NYSE:SYK - Get Free Report) last posted its quarterly earnings results on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, beating analysts' consensus estimates of $4.40 by $0.07. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The firm had revenue of $7.17 billion for the quarter, compared to analysts' expectations of $7.12 billion. During the same quarter in the prior year, the company posted $4.01 earnings per share. The business's revenue for the quarter was up 11.4% on a year-over-year basis. On average, equities research analysts forecast that Stryker Corporation will post 14.92 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st will be issued a dividend of $0.88 per share. The ex-dividend date is Tuesday, March 31st. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. Stryker's dividend payout ratio is presently 41.90%.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on SYK. William Blair reaffirmed an "outperform" rating on shares of Stryker in a research note on Thursday, March 5th. TD Cowen downgraded shares of Stryker from a "buy" rating to a "hold" rating and set a $387.00 target price for the company. in a research note on Monday, January 26th. Truist Financial decreased their target price on shares of Stryker from $395.00 to $380.00 and set a "hold" rating for the company in a research note on Wednesday, April 15th. Citigroup decreased their target price on shares of Stryker from $420.00 to $385.00 and set a "buy" rating for the company in a research note on Tuesday, April 7th. Finally, Barclays reaffirmed an "overweight" rating and set a $469.00 target price on shares of Stryker in a research note on Monday, February 2nd. Fifteen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $421.11.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.